BCT 2 1/2 (BROMOCRIPTINE 2.5 mg)
Pill imprint BCT 2 1/2 has been identified as Bromocriptine mesylate 2.5 mg.
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; tardive dyskinesia; acromegaly and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BCT 2 1/2 (BROMOCRIPTINE 2.5 mg)
BCT 2 1/2
- 2.5 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
Bromocriptine mesylate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...